Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) has earned a consensus recommendation of “Hold” from the four analysts that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $200.00.
A number of analysts have issued reports on the stock. Zacks Research upgraded shares of Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. Weiss Ratings lowered shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Finally, BWS Financial restated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a report on Monday, March 23rd.
View Our Latest Stock Analysis on Hawkins
Insider Buying and Selling at Hawkins
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of HWKN. New York State Common Retirement Fund boosted its stake in shares of Hawkins by 137.5% in the 3rd quarter. New York State Common Retirement Fund now owns 16,302 shares of the specialty chemicals company’s stock valued at $2,979,000 after buying an additional 9,439 shares during the period. Callan Family Office LLC purchased a new stake in shares of Hawkins during the third quarter worth approximately $1,568,000. NewEdge Wealth LLC purchased a new stake in shares of Hawkins during the third quarter worth approximately $935,000. Principal Financial Group Inc. raised its holdings in Hawkins by 12.7% in the third quarter. Principal Financial Group Inc. now owns 113,371 shares of the specialty chemicals company’s stock valued at $20,715,000 after acquiring an additional 12,767 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in Hawkins by 74.6% in the third quarter. Envestnet Asset Management Inc. now owns 24,050 shares of the specialty chemicals company’s stock valued at $4,394,000 after acquiring an additional 10,279 shares in the last quarter. 69.71% of the stock is currently owned by hedge funds and other institutional investors.
Hawkins Trading Up 1.3%
Shares of NASDAQ HWKN opened at $153.60 on Friday. The company has a current ratio of 2.35, a quick ratio of 1.46 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $3.21 billion, a PE ratio of 38.89, a PEG ratio of 3.20 and a beta of 0.82. Hawkins has a twelve month low of $101.72 and a twelve month high of $186.15. The stock has a fifty day simple moving average of $145.01 and a 200-day simple moving average of $149.03.
Hawkins (NASDAQ:HWKN – Get Free Report) last posted its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.03). Hawkins had a return on equity of 16.85% and a net margin of 7.75%.The firm had revenue of $244.08 million for the quarter, compared to analyst estimates of $252.51 million. On average, equities analysts forecast that Hawkins will post 4 earnings per share for the current year.
Hawkins Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were paid a $0.19 dividend. The ex-dividend date was Friday, February 13th. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. Hawkins’s payout ratio is 19.24%.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
See Also
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
